|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 01:58PM
|
|
Re: Positives vs. negatives
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 05:54PM
|
|
Re: Possible FDA already has eGFR information
|
4
|
Resverlogix Corp.
|
Feb 20, 2020 08:04AM
|
|
Re: Potential market
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 04:11PM
|
|
Re: Predictions ......
|
1
|
Resverlogix Corp.
|
Nov 15, 2019 04:37PM
|
|
Re: Q4 2019 Events
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 08:10PM
|
|
Re: Q4 2019 Events
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 09:06PM
|
|
Re: Question about Phase 2
|
2
|
Resverlogix Corp.
|
Mar 12, 2019 09:08AM
|
|
Re: Question about Phase 2
|
2
|
Resverlogix Corp.
|
Mar 12, 2019 09:38AM
|
|
Re: Question about Phase 2
|
1
|
Resverlogix Corp.
|
Mar 12, 2019 10:23AM
|
|
Re: Question about Phase 2
|
6
|
Resverlogix Corp.
|
Mar 12, 2019 11:36AM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
5
|
Resverlogix Corp.
|
Sep 07, 2019 03:24PM
|
|
Re: Random thoughts RVX-208 and COVID-19
|
2
|
Resverlogix Corp.
|
Apr 13, 2020 02:31PM
|
|
Re: Remembering Relypsa
|
5
|
Resverlogix Corp.
|
Nov 30, 2018 09:42AM
|
|
Re: Remembering Relypsa
|
5
|
Resverlogix Corp.
|
Nov 30, 2018 12:10PM
|
|
Re: Remembering Relypsa
|
3
|
Resverlogix Corp.
|
Nov 30, 2018 12:49PM
|
|
Re: Report of exempt distribution
|
3
|
Resverlogix Corp.
|
May 07, 2020 09:36PM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
4
|
Resverlogix Corp.
|
Sep 23, 2019 09:07AM
|
|
Re: Resverlogix Announces Change to its Board of Directors
|
3
|
Resverlogix Corp.
|
Dec 11, 2019 09:38AM
|
|
Re: Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 09:01AM
|
